Feasibility randomised controlled trial of the Early Adolescent Skills for Emotions psychological intervention with young adolescents in Lebanon.
Feasibility trial
Psychological intervention
Refugee mental health
Young adolescents
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
received:
24
08
2022
accepted:
27
01
2023
entrez:
1
3
2023
pubmed:
2
3
2023
medline:
4
3
2023
Statut:
epublish
Résumé
Globally, there is a vast mental health treatment gap, whereby the majority of adolescents living in low- and middle-income countries requiring mental health services, do not have access to adequate care. To improve access, the World Health Organization (WHO) developed a range of interventions, designed to be low-cost and delivered by non-specialists. We conducted a two-arm, individually randomised group treatment feasibility trial of a new WHO group intervention for young adolescents with emotional distress ('Early Adolescent Skills for Emotions'; EASE) in Lebanon. The aim of this study was to determine the feasibility of the intervention and study procedures. Adolescents aged 10 to 14 years were eligible to take part if they scored above a validated cut-off on the Child Psychosocial Distress Screener. Participants were randomized to EASE or enhanced treatment as usual (ETAU) control using a 1:1 ratio. EASE consisted of seven group sessions with adolescents and three sessions with caregivers. ETAU consisted of a single brief psychoeducation home visit. Child and caregiver outcomes were measured by blind assessors at baseline, endline (8 weeks post-randomisation), and three month follow-up (20 weeks post-randomisation), with the primary outcome measure being child psychological symptoms on the Pediatric Symptom Checklist. Qualitative interviews were conducted with adolescents (n = 13), caregivers (n = 17), facilitators (n = 6), trainers (n = 3), and outreach staff (n = 1) at endline to assess barriers and facilitators related to the feasibility and delivery of EASE and study procedures. Of 154 adolescents screened, 67 (43%) were eligible, completed baseline, and were randomized. Sixty adolescents (90%) completed endline assessments (31 EASE, 29 ETAU), and fifty-nine (88%) completed three-month assessments (29 EASE, 30 ETAU). Qualitatively, participants provided overall positive feedback about the intervention. Several challenges and suggestions for improvement were raised around logistics, intervention content, and acceptability of assessment measures. Implementation data highlighted challenges with intervention uptake and attendance. Outcome measures generally had strong psychometric properties (range: α = 0.77 to α = 87), however did not demonstrate change over time in either group. The EASE intervention and study procedures are acceptable and feasible for implementation with vulnerable adolescents in Lebanon, however several improvements are necessary prior to full-scale evaluation. #ISRCTN60799626, retrospectively registered on 04/10/2022.
Sections du résumé
BACKGROUND
Globally, there is a vast mental health treatment gap, whereby the majority of adolescents living in low- and middle-income countries requiring mental health services, do not have access to adequate care. To improve access, the World Health Organization (WHO) developed a range of interventions, designed to be low-cost and delivered by non-specialists. We conducted a two-arm, individually randomised group treatment feasibility trial of a new WHO group intervention for young adolescents with emotional distress ('Early Adolescent Skills for Emotions'; EASE) in Lebanon.
METHOD
The aim of this study was to determine the feasibility of the intervention and study procedures. Adolescents aged 10 to 14 years were eligible to take part if they scored above a validated cut-off on the Child Psychosocial Distress Screener. Participants were randomized to EASE or enhanced treatment as usual (ETAU) control using a 1:1 ratio. EASE consisted of seven group sessions with adolescents and three sessions with caregivers. ETAU consisted of a single brief psychoeducation home visit. Child and caregiver outcomes were measured by blind assessors at baseline, endline (8 weeks post-randomisation), and three month follow-up (20 weeks post-randomisation), with the primary outcome measure being child psychological symptoms on the Pediatric Symptom Checklist. Qualitative interviews were conducted with adolescents (n = 13), caregivers (n = 17), facilitators (n = 6), trainers (n = 3), and outreach staff (n = 1) at endline to assess barriers and facilitators related to the feasibility and delivery of EASE and study procedures.
RESULTS
Of 154 adolescents screened, 67 (43%) were eligible, completed baseline, and were randomized. Sixty adolescents (90%) completed endline assessments (31 EASE, 29 ETAU), and fifty-nine (88%) completed three-month assessments (29 EASE, 30 ETAU). Qualitatively, participants provided overall positive feedback about the intervention. Several challenges and suggestions for improvement were raised around logistics, intervention content, and acceptability of assessment measures. Implementation data highlighted challenges with intervention uptake and attendance. Outcome measures generally had strong psychometric properties (range: α = 0.77 to α = 87), however did not demonstrate change over time in either group.
CONCLUSIONS
The EASE intervention and study procedures are acceptable and feasible for implementation with vulnerable adolescents in Lebanon, however several improvements are necessary prior to full-scale evaluation.
TRIAL REGISTRATION
#ISRCTN60799626, retrospectively registered on 04/10/2022.
Identifiants
pubmed: 36858980
doi: 10.1186/s12888-023-04571-9
pii: 10.1186/s12888-023-04571-9
pmc: PMC9979451
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
131Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Investigateurs
Katie S Dawson
(KS)
Sarah Watts
(S)
Maha Ghatasheh
(M)
May Aoun
(M)
Aiysha Malik
(A)
Felicity L Brown
(FL)
Ceren Acarturk
(C)
Aemal Akhtar
(A)
Ibrahim Akinçi
(I)
Ahmed Bawaneh
(A)
Martha Bird
(M)
Felicity L Brown
(FL)
Richard Bryant
(R)
Sebastian Burchert
(S)
Pim Cuijpers
(P)
Anne de Graaff
(A)
Annelieke Drogendijk
(A)
Daniela Fuhr
(D)
Jonas Maria Hessling
(JM)
Zeynep Ilkkursun
(Z)
Mark J D Jordans
(MJD)
Christine Knaevelsrud
(C)
Gülşah Kurt
(G)
David McDaid
(D)
Saara Martinmäki
(S)
Cansu Mirzanlı
(C)
Trudy Mooren
(T)
Naser Morina
(N)
A-La Park
(AL)
Monique Pfaltz
(M)
Bayard Roberts
(B)
Matthis Schick
(M)
Ulrich Schnyder
(U)
Marit Sijbrandij
(M)
Egbert Sondorp
(E)
Julia Spaaij
(J)
Frederik Steen
(F)
Karine Taha
(K)
Peter Ventevogel
(P)
Claire Whitney
(C)
Nana Wiedemann
(N)
Aniek Woodward
(A)
Informations de copyright
© 2023. The Author(s).
Références
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Behav Res Ther. 2021 Oct;145:103944
pubmed: 34392115
Behav Res Ther. 2015 Jun;69:11-21
pubmed: 25847276
PLoS Med. 2017 Aug 15;14(8):e1002371
pubmed: 28809935
PLoS Med. 2021 Jun 17;18(6):e1003621
pubmed: 34138875
World Psychiatry. 2019 Feb;18(1):105-107
pubmed: 30600639
PLoS Med. 2022 Aug 12;19(8):e1004046
pubmed: 35960704
Pediatrics. 2010 Dec;126(6):1117-23
pubmed: 21041282
Soc Psychiatry Psychiatr Epidemiol. 2002 Nov;37(11):537-43
pubmed: 12395144
Eur J Psychotraumatol. 2021 Nov 29;12(1):1901408
pubmed: 34868475
Lancet. 2018 Oct 27;392(10157):1553-1598
pubmed: 30314863
J Child Psychol Psychiatry. 2017 Apr;58(4):507-524
pubmed: 27943284
Lancet. 2019 Apr 27;393(10182):1733-1744
pubmed: 30948286
JAMA. 2016 Dec 27;316(24):2609-2617
pubmed: 27837602
Trials. 2019 Sep 2;20(1):545
pubmed: 31477178
Epidemiol Psychiatr Sci. 2013 Sep;22(3):197-203
pubmed: 23941725
Lancet Psychiatry. 2020 Feb;7(2):162-172
pubmed: 31948935
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
J Glob Health. 2017 Dec;7(2):020901
pubmed: 29302326
Br J Psychiatry. 2017 Feb;210(2):119-124
pubmed: 27908899
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):667-668
pubmed: 33188854
Lancet. 2019 Jul 20;394(10194):240-248
pubmed: 31200992
PLoS Med. 2018 Mar 9;15(3):e1002524
pubmed: 29522518
Eur Child Adolesc Psychiatry. 2019 Oct;28(10):1295-1310
pubmed: 30151800
J Epidemiol Community Health. 1995 Aug;49(4):431-6
pubmed: 7650469
Psychol Assess. 2016 May;28(5):613-625
pubmed: 26348028
Lancet Glob Health. 2018 Apr;6(4):e390-e400
pubmed: 29530422
Front Psychiatry. 2020 Mar 23;11:212
pubmed: 32265759
Am J Orthopsychiatry. 2008 Jul;78(3):290-9
pubmed: 19123748
Child Adolesc Psychiatry Ment Health. 2022 Jun 21;16(1):47
pubmed: 35729589